For instance, although there is a significant body of evidence suggesting that inhibition of DRP1 activity can inhibit mitochondrial fission, while improving heart function and inhibiting the progression of heart disease, a recent study reported that inhibiting mitochondrial fission by enhancing fusion leads to different cardiac outcomes. Here, DNM1L is linked to heart disorder.